Macquarie Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-613	Closed	-$3	–	2184
2024 Q1	$3	Buy	+613	New	+$3	﹤0.01%	1840
2018 Q1	–	Sell	-90	Closed	-$9K	–	2398
2017 Q4	$9K	Buy	+90	New	+$9K	﹤0.01%	2285